[Previous Months][Date Index][Thread Index][Join - Register][Login]
[Message Prev][Message Next][Thread Prev][Thread Next]

[IP] references from the editorial (including email addy!)



>From the Department of Medicine and Pediatrics, McGill University, and the 
Division of Endocrinology, Jewish General Hospital, Montreal, Quebec, Canada.

Address correspondence to Alicia Schiffrin, MD, Division of Endocrinology, 
E-104, Jewish General Hospital, 3755 Cote Ste. Catherine Rd., Montreal, PQ, 
H3T 1 E2 Canada. E-mail: email @ redacted


------------------------------------------------------------------------------
--

References
1. Pickup JC, Keen H, Parsons JA, Alberti KG: Continuous subcutaneous insulin 
infusion: an approach to achieving normoglycaemia. Br Med J 1:204–207, 1978

2. Tamborlane WV, Sherwin RS, Genel M, Felig P: Reduction to normal of plasma 
glucose in juvenile diabetics by subcutaneous administration of insulin with 
a portable infusion pump. N Engl J Med 300:573–578, 1979

3. Schiffrin A, Belmonte M, Colle E: Improved control in diabetes with 
continuous subcutaneous insulin infusion. Diabetes Care 3:643–647, 1980

4. Schiffrin A, Belmomte M: Comparison between continuous subcutaneous 
insulin infusion and multiple injections of insulin. Diabetes 31:479–483, 1982

5. Becker DJ, Kerensky KM, Transue D, Gutai J, Nathan S, Wolfson D, Drash A: 
Current status of pump therapy in childhood. Acta Paediatr Jpn 26:347–358, 
1984

6. Brink SJ, Stewart C: Insulin pump treatment in insulin-dependent diabetes 
mellitus. JAMA 255:617–621, 1986

7. Bougnères PF, Landier MD, Lemmel C, Mensire A, Chaussain JL: Insulin pump 
therapy in young children with type 1 diabetes. J Pediatr 105:212–217, 1984

8. de Beaufort CE, Bruining GJ: Continuous subcutaneous insulin infusion in 
children. Diabet Med 4:103–108, 1987

9. Knight G, Boulton AJM, Ward JD: Experience of continuous subcutaneous 
infusion in the outpatient management of diabetic teenagers. Diabet Med 
3:82–84, 1986

10. Levy-Marchal C, Czernichow P: Feasibility of continuous subcutaneous 
infusion in young diabetic patients. Diabete Metab 14:108–113, 1988

11. Schiffrin AD, Desrosiers M, Aleyassine H, Belmonte MM: Intensified 
insulin therapy in the type 1 diabetic adolescent: a controlled trial. 
Diabetes Care 7:107–113, 1984

12. Schiffrin A, Desrosiers M, Moffat M, Belmonte M: Feasibility of tight 
diabetes control in insulin-dependent diabetic adolescents. J Pediatr 
103:522–527, 1983

13. Schiffrin A, Belmonte M: Combined continuous subcutaneous insulin 
infusion and multiple subcutaneous injections in type 1 diabetic patients. 
Diabetes Care 4:595–600, 1981

14. The Diabetes Control and Complications Trial Research Group: The effects 
of intensive treatment of diabetes on the development and progression of 
long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 
329:977–986, 1993

15. Blackett PR: Insulin pump treatment for recurrent ketoacidosis in 
adolescence. Diabetes Care 18:881–882, 1995

16. Steindel BS, Roe TF, Costin G, Carlson M, Kaufman F: Continuous 
subcutaneous insulin infusion in children and adolescents with chronic poorly 
controlled type 1 diabetes mellitus. Diabetes Res Clin Pract 27:190–204, 1995

17. Bougnères PF, Landais P, Miresse AM, Jais JP, Jos J, Peyraud J, Wieliczko 
MC, Chavoix P, Garandeau P, Asensi D, Ythier H, Pouland V, Mazoyer T, Leturcq 
F, Raynaud E: Improvement of diabetic control and acceptability of a 
three-injection insulin regimen in diabetic adolescents: a multicenter 
controlled study. Diabetes Care 16:94–102, 1993

18. Kaufman FR, Halvorson M, Kim C, Pitukcheewanont P: Use of insulin pump 
therapy at nighttime only for children 7–10 years of age with type 1 
diabetes. Diabetes Care 23:579–582, 2000

19. Kanc K, Janssen MMJ, Keulen ET, Jacobs MA, Popp-Snijders C, Snoek FJ, 
Heine RJ: Substitution of night-time continuous subcutaneous insulin infusion 
therapy for bedtime NPH insulin in a multiple injection regimen improves 
counterregulatory hormonal responses and warning symptoms of hypoglycemia in 
IDDM. Diabetologia 41:322–329, 1998

20. The Diabetes Control and Complications Trial Research Group: 
Implementation of treatment protocols in the Diabetes Control and 
Complications Trial. Diabetes Care 18:361–376, 1995

21. Norfeldt S, Ludvigsson J: Severe hypoglycemia in children with IDDM: a 
prospective population study, 1992–1994. Diabetes Care 20:497–503, 1997

22. Matyka K, Crowne E, Havel P, MacDonald I, Matthews D, Dunger D: 
Counterregulation during spontaneous nocturnal hypoglycemia in prepuberal 
children with type 1 diabetes. Diabetes Care 22:1144–1150, 1999

23. Hershey T, Hargava N, Sadler M, White N, Craft S: Conventional versus 
intensive diabetes therapy in children with type 1 diabetes: effects on 
memory and motor speed. Diabetes Care 22:1318–1324, 1999

24. The Diabetes Control and Complications Trial Research Group: Hypoglycemia 
in the Diabetes Control and Complications Trial. Diabetes 46:271–286, 1997

25. Bergada I, Suissa S, Dufresne J, Schiffrin A: Severe hypoglycemia in IDDM 
children. Diabetes Care 12:239–244, 1989

26. Bolli G, Fanelli C, Perriello G, De Feo P: Nocturnal blood glucose 
control in type 1 diabetes mellitus. Diabetes Care 16 (Suppl. 3):71–89, 1993

27. Schiffrin A, Suissa S: Predicting nocturnal hypoglycemia in patients with 
type 1 diabetes treated with continuous subcutaneous insulin infusion. Am J 
Med 82:1127–1132, 1987

28. Koivisto VA, Yki-Jarvinen H, Helve E, Karonen SL, Pelkonen R: 
Pathogenesis and prevention of the dawn phenomenon in diabetic patients 
treated with CSII. Diabetes Care 35:78–82, 1986

----------------------------------------------------------
for HELP or to subscribe/unsubscribe, contact: HELP@insulin-pumpers.org
send a DONATION http://www.Insulin-Pumpers.org/donate.shtml